HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries

This Week in 340B: June 23 – 29, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Rebate Model; Other

  • In an appealed case brought by a drug manufacturer challenging a North Dakota state law governing contract pharmacy arrangements, a group of amici filed an amicus curiae brief.
  • In five cases brought by drug manufacturers challenging a Utah state law governing contract pharmacy arrangements, the plaintiffs files opposition briefs to the state government’s motions to dismiss.
  • In a case brought by a drug manufacturer seeking judgment on its interpretation of the definition of “patient”, a group of proposed intervenors filed a motion to intervene.
  • In an appealed case challenging the 340B Rebate Model Pilot Program, a group of manufacturers filed a reply brief regarding the denial of their motion to intervene.
  • In one appealed case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the defendant-appellee filed a response brief.
  • In a case brought by a group of 340B covered entities, the U.S. District Court for the Western District of New York issued a [...]

    Continue Reading



This Week in 340B: June 16 – 22, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In an appealed case brought by a drug manufacturer challenging a North Dakota state law governing contract pharmacy arrangements, the defendant-appellants filed their brief.
  • In one case brought by a drug manufacturer challenging an Oregon state law governing contract pharmacy arrangements, intervenor Oregon Primary Care Association filed a cross-motion for summary judgement and response to plaintiff’s motion for summary judgment.
  • In one case brought by a drug manufacturer challenging an Oregon state law governing contract pharmacy arrangements, amici curiae filed a brief in support of defendants’ motion for summary judgement.
  • In one appealed case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the Department of Justice filed an amicus brief in support of the plaintiff-appellants.



This Week in 340B: June 9 – 15, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In a case by a covered entity against an insurance company alleging breach of contract, the insurance company filed an amended answer and counterclaims to the covered entity’s complaint.
  • In a case brought by a 340B Covered Entity against the government to challenge the government’s policy regarding GPO arrangements, the parties filed a stipulation of dismissal pursuant to their settlement agreement.
  • In one appealed case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the plaintiff-appellants filed their opening brief, and in a second, similarly appealed case, the Department of Justice filed an amicus brief in support of the plaintiff-appellants.
  • In a case brought by a drug manufacturer challenging a Colorado state law governing contract pharmacy arrangements, the court granted the defendants’ motion to dismiss.
  • In two cases brought by a drug manufacturer challenging an Oregon state law governing contract pharmacy arrangements, defendants filed a motion for summary judgement and opposition to plaintiff’s motion for summary [...]

    Continue Reading



This Week in 340B: June 2 – 8, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In a case against HRSA challenging its certification of a group of entities as 340B-eligible, the federal government and intervenor-defendant each filed a reply in support of the federal government’s motion for summary judgment.
  • In a case challenging the government’s rebate model pilot program, the plaintiff-appellees filed a brief regarding the district court’s denial of a motion to intervene filed by a group of drug manufacturers and a trade association of trade manufacturers.
  • In a case brought by a drug manufacturer challenging an Oregon state law governing contract pharmacy arrangements, intervenor Oregon Primary Care Association filed a reply in support of its cross-motion for summary judgment.
  • In a case brought by a drug manufacturer against the federal government, the intervenor-defendant filed a summary judgement reply brief and the defendant filed a reply in further support of the defendants’ motion for summary judgement.
  • In a consolidated case brought by a drug manufacturer and trade association for drug manufacturers challenging a Hawaii state [...]

    Continue Reading



This Week in 340B: May 26 – June 1, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In a case brought by a trade association of drug manufacturers challenging an Oregon state law governing contract pharmacy arrangements, intervenor Oregon Primary Care Association filed a reply in support of its cross-motion for summary judgment.
  • In a case brought by a drug manufacturer challenging a New Mexico state law governing contract pharmacy arrangements, the court denied the plaintiff’s motion for preliminary injunction.
  • In a case brought by a drug manufacturer challenging a Hawaii state law governing contract pharmacy arrangements, the plaintiff filed a stipulated motion to hold the case in abeyance. On May 29, 2026, the court granted the motion.
  • In an appealed case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the plaintiff-appellant filed a brief.
  • In a case challenging a state law in Maryland, the court granted an order to rehear the case en banc.
  • In a case brought by 340B covered entities against a group of pharmacy benefit managers and their [...]

    Continue Reading



STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm
U.S. News Law Firm of the Year 2022 Health Care Law